Telix Pharmaceuticals Investors: Deadline approaching to Join Securities Fraud Lawsuit
NEW YORK,NY – December 19,2025 – Investors who purchased Telix Pharmaceuticals Ltd. (TLX) stock between February 21, 2025, and August 28, 2025, have until January 9, 2026, to seek recovery of losses stemming from alleged securities fraud. The law firm Levi & Korsinsky LLP has filed a class action lawsuit against Telix Pharmaceuticals, alleging the company made false and misleading statements regarding its business operations and prospects.
The lawsuit claims Telix pharmaceuticals misrepresented the progress of its prostate cancer therapeutic candidates and overstated the quality of its supply chain and partnerships. These alleged misrepresentations, according to the complaint, resulted in materially false and misleading statements about the company’s overall business.
Investors who experienced losses during the specified period – even those who continue to hold their shares – are encouraged to explore their legal options.There is no cost or obligation to participate.
Levi & Korsinsky LLP, a nationally-recognized securities litigation firm, is leading the case. The firm states it has recovered hundreds of millions of dollars for shareholders and consistently ranks among the top securities litigation firms in the United States, appearing in ISS Securities Class Action Services’ Top 50 Report for the past seven years.
Interested investors can submit their information through the firm’s website at https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=178738&wire=1&utm_campaign=21 or contact attorney Joseph E. Levi directly at jlevi@levikorsinsky.com or (212) 363-7500.
CONTACT:
Levi & korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
